by StepChange Innovations GmbH
Login Status
You are not logged in.

Categories
Newsletter
Receive abstracts of new posts by e-mail
* = required field
Data Privacy

Sponsored Ads

patents

Indian government forces Bayer to accept generic Nexavar competition – FiercePharma

India has invoked its compulsory licensing rules for the first time to make and sell a version of Bayer's cancer drug Nexavar despite the fact that Nexavar is still on patent. We think this is quite a significant development. What does it mean for ROI of big pharma companies R&D ? What does it mean for IP integrity for doing business in India ?
Continue reading
Sponsored Ads
Archives
Disclosure
Legal Disclosure
Data Privacy
Copyright Information: Images: © Fotolia
Calendar
August 2018
M T W T F S S
« May    
 12345
6789101112
13141516171819
20212223242526
2728293031  

Copyright © 2013. All Rights Reserved.